Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07785596Completed
Trial of serrapeptase in post-operative inflammation, postoperative edema and postoperative pain (2 arms), sponsored by Kharadar General Hospital. Primary endpoint: Post-operative facial swelling at 72 hours. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07785596.